The problems of meta-analysis for antibiotic treatment of chronic obstructive pulmonary disease, a heterogeneous disease: a commentary on Puhan et al
<p>Abstract</p> <p>Exacerbations are a major cause of morbidity and mortality in chronic obstructive pulmonary disease. Exacerbations can be of bacterial, viral or mixed etiology, with bacteria involved in 50% of exacerbations. Consequently, current management of exacerbations freq...
Main Author: | Sethi Sanjay |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-10-01
|
Series: | BMC Medicine |
Online Access: | http://www.biomedcentral.com/1741-7015/6/29 |
Similar Items
-
Prophylactic antibiotic therapy in chronic obstructive pulmonary disease
by: Tommaso Maraffi, et al.
Published: (2010-06-01) -
Current Antibiotic Choice in Chronic Obstructive Pulmonary Disease
by: Mehmet BAKIR
Published: (2003-03-01) -
Are prophylactic antibiotics useful in chronic obstructive pulmonary disease?
by: Alex Arenas, et al.
Published: (2015-12-01) -
The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease
by: Ilya Berim, et al.
Published: (2011-06-01) -
Antibiotics for treatment of acute exacerbation of chronic obstructive pulmonary disease: a network meta-analysis
by: Hai-Lin Zhang, et al.
Published: (2017-12-01)